Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.

• Main Authors: Phirangkul Kerdpanich (Author), Pornthep Chanthavanich (Author), Mari Rose De Los Reyes (Author), Jodor Lim (Author), Delia Yu (Author), Ma Cecilia Ama (Author), Zenaida Mojares (Author), Daniela Casula (Author), Ashwani Kumar Arora (Author), Michele Pellegrini (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared with the currently recommended 2-site/Thai Red Cross (TRC) reg...